Clinical Trials Directory

Trials / Completed

CompletedNCT01090037

TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

TRK-100STP PhaseIIb/III Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
892 (actual)
Sponsor
Toray Industries, Inc · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In Chronic Renal Failure (CRF) patients with primary glomerular disease or nephrosclerosis as the primary disease: * To confirm the superiority of TRK-100STP over placebo * To determine the recommended therapeutic dose in the 2 doses of TRK-100STP * To assess the safety of TRK-100STP

Conditions

Interventions

TypeNameDescription
DRUGTRK-100STP high dose
DRUGTRK-100STP low dose
DRUGPlacebo

Timeline

Start date
2010-03-01
Primary completion
2014-08-01
Completion
2015-01-01
First posted
2010-03-19
Last updated
2015-02-04

Locations

7 sites across 7 countries: China, Hong Kong, Japan, Malaysia, South Korea, Taiwan, Thailand

Source: ClinicalTrials.gov record NCT01090037. Inclusion in this directory is not an endorsement.